Echo Pharmaceuticals

Curated by Signal

Developer of cannabinoid medicines to treat various disease conditions

Overview

Developer of cannabinoid medicines to treat various disease conditions. The company focuses on the development of drug delivery technologies and cannabinoid-based medicines Namisol and Arvisol for pain and neurological conditions.

Key facts

Founded: 2006
Headquarters: Leiden, Netherlands
Stage: Sign up to view
Industry: Health Technology

Business model

5 products and services: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

NootroFit
Online retailer offering nutritional supplements
Health TechnologyDeventer, Netherlands
Avinty
Digital care planning and management tool for providers
Health TechnologyOldenzaal, Netherlands
HLA-EMMA
Cloud-based administrative management software for healthcare professionals
Health TechnologyLeiden, Netherlands

About Echo Pharmaceuticals

What does Echo Pharmaceuticals do?

Developer of cannabinoid medicines to treat various disease conditions.

Where is Echo Pharmaceuticals headquartered?

Echo Pharmaceuticals is headquartered in Leiden, Netherlands.

When was Echo Pharmaceuticals founded?

Echo Pharmaceuticals was founded in 2006.

Which sector is Echo Pharmaceuticals in?

Echo Pharmaceuticals operates in Health Technology.

Who are Echo Pharmaceuticals's competitors?

Companies similar to Echo Pharmaceuticals include NootroFit, Avinty, and HLA-EMMA.